About Us

Kevin Klock

Scholar, O’Neill Institute for National and Global Health Law

Kevin A. Klock is Director of Operations and Advisor to the President for the Foundation for the National Institutes of Health. He is responsible for working with all internal departments to facilitate the management of the FNIH. He provides legal counsel and advice, oversees grants and contracts, manages human resources and office infrastructure, and leads special projects. In addition, he serves as a critical thought partner to the President and senior leadership and administers many aspects of the Foundation’s governance.

Previously, Klock was Head of Governance and Assistant Secretary for Gavi, the Vaccine Alliance, and Company Secretary for the Gavi Campaign. At Gavi he advised board members, staff, and partners on public sector and corporate governance best practice and was lead staff member on governance for matters that involved Gavi's finance and debt-issuance activities including the International Finance Facility for Immunisation (IFFIm). Prior to this he was with the National Association of Corporate Directors (NACD), which provides research and education to corporate boards.

Klock has served as a director on three boards and his comments on corporate governance have appeared in many industry publications. He lectures regularly on global health and governance issues and has been published by Oxford University Press and the Georgetown Journal of International Law, among others.

Klock received his Juris Doctor, magna cum laude, from Georgetown University Law Center and is a member of the District of Columbia Bar. He is a graduate of Duke University, received his MA from American University, and was Lord Rothermere Scholar at Oxford University.

PUBLICATIONS

International Public-Private Partnerships as Part of the Solution to Infectious Disease Threats in Global Management of Infectious Disease After Ebola, in GLOBAL MANAGEMENT OF INFECTIOUS DISEASE AFTER EBOLA. Oxford University Press, 2016.

The Soft Law Alternative to the WHO’s Treaty Powers, 44 GEO. J. INT’L L. 821 (2013).

Breaking the Mold: How Arcadec Overhauled its Strategy, in REPORT OF THE NACD BLUE RIBBON COMMISSION ON THE ROLE OF THE BOARD IN CORPORATE STRATEGY (2006 ed.).

New Executive Compensation Disclosure Rules in 2006?, DIRECTORS MONTHLY EXTRA, Dec. 1, 2005 (with Alexandra R. Lajoux).

We Hear You: PCAOB Releases Section 404 Guidance, DIRECTORS MONTHLY EXTRA, May 17, 2005.